Okupres-e

Roman name

Ocupres-E

The composition and the form of

1 ml timolola contains 2.5 or 5.0 mg (as maleate); in vials to 5 ml, in a box one bottle.

Of drugs

Protivoglaucomnoe. Beta-adrainoretseptora block. Impact products vnutriglazna liquids, and normal high inner pressure without affecting pupil size and the severity of view.

Clinical pharmacology

Lower vnutriglaznogo the pressure after 30 minutes after a single backfilling. The maximum effect is achieved in 1-2 hours, and continues over the next 24 hours The effect was also being felt in cases resistant to other protivoglaucomnam drugs. Decreases of gipoglikemii diabetes.

Indications

Glaucoma (otkratougolnaya, chronic, afakica, secondary).

Contraindications

Bronchial asthma and chronic obstructive lung diseases, sinusova aetiology, AV blockade of I and II degrees expressed cardiac insufficiency, cardiogenny shock severe rhinitis expressed dystrophic diseases cornea.

Side-Effects

Heat and light eye irritation, the fog, keratit, dizziness, insomnia, depression, aetiology and hypotension, AV blockade, heart failure, bronhospazm, allergic reactions.

Patient interaction

Simpatolitiki, calcium antagonists and the appointment system бета-адреноблокаторо�� potenziruet tissues, bradycardia and oppression AV conduction. Do effect of catecholamine, naperstanki drugs. Step increases miotikami, carboangidraza inhibitors.

Precautions

To use caution in patients with contraindications to systematically receive beta-adrenoblokatorov with bronchial spasm, chronic heart failure and other cardiac diseases. There is a need to control the inner pressure. With long-term therapy should monitor the pulse and AD. If it is necessary to intubatingo narcosis with miorelaksantov drug to be introduced for 48 hours.

Dosing and Administration

Kongungualno. The recommended initial dose of 1 drop of 0.25% solution of 2 times / sut. If the response is insufficient, using 0.5% solution. The stabilization vnutriglaznogo pressure 1x / sut.

Directory → Wegetotropona funds → Adrainoliticaskie funds → Beta-adrenoblokatora → Okupres-e